Bruker (BRKR) Operating Expenses (2010 - 2026)

Bruker (BRKR) has reported Operating Expenses for 17 consecutive years, with $481.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 39.1% year-over-year to $481.3 million; the trailing twelve-month figure through Jun 2026 stood at $1.7 billion (up 12.03% YoY), and the FY2025 full-year result was $1.5 billion, up 8.1% from the prior year.
• Operating Expenses advanced to $481.3 million in Q2 2026 per BRKR's latest filing, from $369.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $481.3 million in Q2 2026 and bottomed at $204.0 million in Q3 2022.
• Historically, Operating Expenses has averaged $317.0 million across 5 years, with a median of $331.6 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses jumped 39.12% in 2023, then slipped 11.47% in 2025.
• Over 5 years, Operating Expenses stood at $234.9 million in 2022, then soared by 39.12% to $326.8 million in 2023, then grew by 28.89% to $421.2 million in 2024, then slipped by 11.47% to $372.9 million in 2025, then grew by 29.07% to $481.3 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $481.3 million, $369.6 million, and $372.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.